Axumin™ (fluciclovine F 18) Image Interpretation Training
Axumin™ (fluciclovine F 18) Image Interpretation Training
Axumin™ (fluciclovine F 18) Image Interpretation Training 

Member and Non-member Fee:  FREE


Authors:

David Schuster, MD

Division of Nuclear Medicine and Molecular Imaging, Emory University

 

Target Audience

This 90-minute (approximately) course contains information of value to physicians in nuclear medicine, radiology, oncology, and urology using Axumin® (fluciclovine F 18), a radioactive diagnostic agent indicated for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on elevated blood prostate specific antigen (PSA) levels following prior treatment.  This course is intended for physicians, nuclear medicine technologists, and any professionals in the nuclear medicine and related fields.

NOTE:  At the end of each case presentation, the narrator instructs the viewer to go to the DICOM case; the DICOM cases will be available soon!

Objectives

At the completion of this activity, the participant will be able to:

  1. Describe the mechanism of action of fluciclovine F 18
  2. Identify the normal biodistribution in these scans
  3. Understand expected physiologic uptake patterns, incidental findings and normal variants
  4. Interpret fluciclovine F 18 PET/CT scans

Continuing Education Credit Information

This course does not offer continuing education credits.  Upon successful completion of the assessment, participants will receive a certificate of training. 

Minimum system requirements

Supported Internet Browsers:
- Microsoft Internet Explorer (version 7 or higher)
- Google Chrome (latest version)
- Mozilla Firefox (latest version)
- Apple Safari (version 4 or higher)

Plug-in: Adobe Acrobat Reader (http://get.adobe.com/reader/)

For questions please contact the Education Department 703-708-9000.
© 2016 Blue Earth Diagnostics Inc. All rights reserved.


Type:     Internet Activity (Enduring Material)
802 Registered Users